Dr. Owen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
460 W 10th Ave
Columbus, OH 43210Phone+1 614-293-6529
Education & Training
- The Ohio State UniversityM.Sc., Clinical Research, 2015 - 2017
- Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2014 - 2017
- New York Presbyterian Hospital (Cornell Campus)Chief Residency, Internal Medicine, 2013 - 2014
- SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 2010 - 2013
- University College of Dublin National Univ SOMClass of 2010
Certifications & Licensure
- OH State Medical License 2014 - 2026
- NY State Medical License 2013 - 2015
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Evaluating the effect of immune checkpoint inhibitor treatment on chronic obstructive pulmonary disease in lung cancer patients.Anet Greib, Songzhu Zhao, Michelle Ploch, Jonathan Henricks, Robert Easterling
Oncoimmunology. 2025-12-01 - 1 citationsBiomechanical Performance of Total Wrist Arthrodesis Plates With and Without Arthrodesis of the Carpometacarpal Joint.David H Owen, Dongyang Wang, Xu Cong, Cameron Mowbray, Diana M Perriman
Hand. 2025-03-01 - Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembr...Alessio Cortellini, Leonardo Brunetti, Giuseppina Rita Di Fazio, Edoardo Garbo, David J Pinato
Journal for Immunotherapy of Cancer. 2025-02-04
Press Mentions
- “Really Impactful” New Guidelines for Stage IV NSCLC With Driver AlterationsAugust 9th, 2023
- 'No' to Anti-VEGF-Chemo Combo in NSCLC Sans Driver AlterationsFebruary 10th, 2023
- High BMI Linked to Better Survival for Cancer Patients Treated with ICI, but for Men OnlySeptember 22nd, 2022
- Join now to see all
Professional Memberships
- Fellow
- Member
- Member
- Member
- Member
- International Association for the Study of Lung CancerMember
- North American Neuroendocrine Tumor SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: